Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free, 8 fl. oz.(240 mL), Distributed by: Taro Pharmaceuticals, U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-2130-1
Published November 6, 2019 · Recall initiated: September 27, 2019
Summary
FDA records drug Class II recall D-0301-2020, published November 6, 2019 and initiated September 27, 2019. Recalling firm: Taro Pharmaceuticals U.S.A., Inc.; Status: Terminated; Reported quantity: 5,190 bottles; Lot: Lot #: J871033187, Exp 9/20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
What to do
Voluntary: Firm initiated · Letter
Get an email if IBUPROFEN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- IBUPROFEN
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Distributor
- U.S.A. Nationwide
- Lot
- Lot #: J871033187, Exp 9/20
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAChildren's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: TaroMarch 25, 2026
- FDAIbuprofen Tablets USP, 400 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-5853-61June 15, 2022
- FDAIbuprofen Oral Suspension USP, 100 mg/5 mL, One Pint, (473 mL), Rx only, Manufactured by: Taro PharmaceuticalsNovember 6, 2019
- FDAMero Macho Artificially Flavored Passion Fruit Vitamin C Liquid Supplement, 2.04 fl oz (60 mL) bottle,November 6, 2019
- FDATestosterone Cypionate Injection, USP, 2000 mg/10 mL, 1 mL Vial, Single-Dose, Rx only, Mfd. for: WilshireNovember 6, 2019
- FDAIbuprofen Tablets USP 400 mg, a) 100 tablet (NDC 49483-602-01) and b) 500 tablet (NDC 49483-602-50) bottles,May 2, 2018
Questions about this recall
Was Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free, 8 fl. oz.(240 mL), Distributed by: Taro Pharmaceuticals, U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-2130-1 recalled?
Yes. FDA published recall D-0301-2020 on November 6, 2019. Reported hazard: Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: IBUPROFEN.